- Tennessee Attorney General warns of dangerous counterfeit GLP-1 weight loss drugs The Tennessean
- Fat jabs are changing the world. It’s time to embrace them The Telegraph
- After key conference, here’s how the race to a $150 billion weight-loss drug market is shaping up MarketWatch
- Beyond GLP-1s: Rethinking Obesity Treatment for the Long Term Technology Networks
- Ozempic boom could make weight loss drugs bigger than statins Quartz